Latest News
Friday, May 03, 2019
Isradipine Shows No Benefit for Parkinson’s Disease
A study of the blood pressure drug isradipine does not show benefit for people with Parkinson’s disease, according to findings that will be presented at the American Academy of Neurology An…
Read the full storyThursday, May 02, 2019
Clinical Trial of Phosphodiesterase Inhibitor Begins for Treatment of Early Alzheimer’s Disease
A phase 2 clinical trial has begun for a novel phosphodiesterase-4D (PDE4D) inhibitor, BPN14770 (Tetra Discovery Partners, Grand Rapids, MI)for potential improvement of improve cognition and memo…
Read the full storyThursday, May 02, 2019
Last Patient Fully Assessed in Trial of Accordion Formulation of Levodopa/Carbidopa for Parkinson’s Disease
The final patient completed their last physician visit in a pivotal phase 3 clinical trial for the accordion pill formulation of carbidopa/levodopa (AP-CD/LD) (Intec Pharma, Jerusalem, Israel) for tre…
Read the full storyWednesday, May 01, 2019
Tofersen for Treatment of Familial Amyotrophic Lateral Sclerosis
An early-stage trial for tofersen (BIIB067; Biogen, Cambridge, MA) an investigational drug for amyotrophic lateral sclerosis (ALS), showed that the drug is linked to slower progression of a form of th…
Read the full storyWednesday, May 01, 2019
Young Blood Plasma for Parkinson's Disease
Results of a clinical trial that administered blood plasma from donors, age 18 to 25 years, into individuals with Parkinson's disease resulted in significant improvements in neurologic assess…
Read the full storyTuesday, April 30, 2019
Humanized Antibody Targets Tau Protein in Alzheimer’s Disease
A Harvard Medical School study demonstrates that a humanized monoclonal antibody (TBL-100; TAU BIOLOGIC Corporation, New York, NY) targets C-terminally truncated tau (tauC3) for the treatment of Alzhe…
Read the full storyThursday, April 25, 2019
Phase 2 Study of Oral Treatment for Essential Tremor
A small molecule T-type calcium channel inhibitor (CX-8998; Cavion, Charlottesville, VA) is showing signs of efficacy for treatment of essential tremor. Using the Tremor Research Group Essential Tremo…
Read the full storyWednesday, April 24, 2019
Nusinersen Efficacy for Later-Onset Spinal Muscular Atrophy Types II and III
April 24, 2019 -- Children with later-onset spinal muscular atrophy (SMA) types II and III treated with nusinersen (Spinraza; Biogen, Cambridge MA) had motor function improvement and disease stabiliza…
Read the full storyWednesday, April 24, 2019
Minimally Invasive Removal of Deep Subcortical Hemorrhage
Minimally invasive techniques have been used to treat deep subcortical hemorrhages successfully. In 2 abstracts, presented at the American Association of Neurological Surgeons (AANS) Annual Scientific…
Read the full storyTuesday, April 23, 2019
$1.5 Million in Community Grant Funding from The Parkinson’s Foundation
More than $1.5 million in community grants from The Parkinson's Foundation were announced. The grants will support education, wellness, and local health programs that address unmet needs for peopl…
Read the full storyFriday, April 19, 2019
Safety and Efficacy of Web Aneurysm Embolization System
Clinical trial results published in the online edition of the Journal of Neurointerventional Surgery showed positive clinical outcomes for an aneurysm embolization system (Web aneurysm embol…
Read the full storyThursday, April 18, 2019
Blood Test for TBI Licensed for Use and Development on Abbot Laboratory Instruments
A Food and Drug Administration (FDA) approved blood test for mild traumatic brain injury (mTBI), also known as concussion, may become more widely available soon. The blood test (Banyan Brain Trauma In…
Read the full storyWednesday, April 17, 2019
Research Agenda Created for Women Living with Parkinson's Disease
The Parkinson's Foundation Women and Parkinson’s Initiativeis the first patient-centered action agenda for improving quality of life for women with Parkinson's disease. The program …
Read the full storyTuesday, April 16, 2019
Promising Results Published for Pembrolizumab to Treat Progressive Multifocal Leukoencephalopathy
As published in the New England Journal of Medicine, positive results have been seen in a small study of pembrolizumab (Keytruda; Merck, Kenilworth, NJ) for treatment of progressive multifocal le…
Read the full storyTuesday, April 16, 2019
Free Resource for People Living With Migraine—Migraine Patient Guidelines
A new publication for people living with migraine, Migraine Patient Guidelines from The Global Healthy Living Foundation, is available for free download to assist people living with migraine…
Read the full story
